• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2007, the patient underwent spine fusion surgery on the thoracic and lumbar region at levels t4-s1.The patient was implanted with rhbmp-2 collagen sponge which was applied from posterior approach.The rhbmp-2 collagen sponge was used to fuse more than one level of the spine and was placed outside a cage (i.E.In the posterolateral gutters).Post-op, the patient complained of progressively worsening low back pain with radiculopathy in her lower extremities, due to which patient underwent for 4 revision surgeries.The patient underwent spine fusion surgery on the thoracic and lumbar regions at levels t12-s1.The patient was implanted with rhbmp-2 collagen sponge to the thoracic spine which was applied from posterolateral approach.The rhbmp-2 collagen sponge was used to fuse more than one level of the spine and was placed outside a cage (i.E.In the posterolateral gutters).
 
Manufacturer Narrative
(b)(4): neither the device nor applicable medical records or imaging studies were returned nor provided for evaluation.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on: (b)(6) 2008: patient presented with pre-op diagnoses: nonunion, flat back deformity, spinal stenosis.Procedure: removal of segmental spinal instrumentation.Exploration of fusion, spinal segmental instrumentation t4-s1.Bilateral iliac fixation.T12-s1 bilateral posterolateral fusion with local autogenous bone, 2 large kits, bmp and 10 cc of bone graft matrix.Per operative notes: two large kits of bmp and 10 cc of bone graft matrix were placed.No other information was provided.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key4861009
MDR Text Key5851054
Report Number1030489-2015-01261
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 03/11/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/11/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-